Kremsner PG, Ahuad Guerrero RA, Arana-Arri E, Aroca Martinez GJ, et al. Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial. Lancet Infect Dis 2021 Nov 23. pii: S1473-3099(21)00677.
PMID: 34826381